Healthcare

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Ainos Plans To Conduct the Study at National Taiwan University Hospital, a Premier Taiwanese Medical Center for HIV ManagementThe U.S....

Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology

Philips LumiGuide Procedure JPG Philips LumiGuide JPG Enhanced longer version of Philips LumiGuide Navigation Wire enables US clinicians to visualize...

Verily Sightline Expands Wastewater Testing Services to Europe Through Partnership with Bangor University in Wales

Exclusive partnership brings Verily’s innovative wastewater surveillance technology to the United Kingdom DALLAS--(BUSINESS WIRE)--Today, Verily, a precision health technology company,...

Patient Engagement Tech Market to Grow by USD 37.4 Billion (2024-2028) with Chronic Disease Rise, AI’s Influence on Market Trends – Technavio Report

NEW YORK, Sept. 16, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global patient engagement technology...

Lab Automation Market to Reach $11.31 Billion by 2031, Driven by Rising Pharmaceutical & Biotech R&D Expenditures and Increasing Demand for Automated Laboratories and Instruments – Report by Meticulous Research®

Anervea Welcomes Jack Capponi as Chief Commercial Officer and Board Member, Driving Global Expansion with AI-Powered Solutions

ORLANDO, Fla., Sept. 16, 2024 /PRNewswire/ -- Anervea.ai, a global leader in AI-powered commercialization solutions for the Pharmaceutical, Life Sciences,...

Velsera Technology Paves the Way for Advanced Cancer Diagnostics with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD

Empowered by Velsera's Knowledge Base and Tumor Profiling Expertise Across U.S. Laboratories BOSTON, Sept. 16, 2024 /PRNewswire/ -- Velsera, a...

error: Content is protected !!